AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

INTEGRAL DIAGNOSTICS LTD

2.270

+0.0200.89%

Volume:733.79K

Turnover:1.67M

Market Cap:844.93M

PE:112.47

High:2.300

Open:2.270

Low:2.260

Close:2.250

Loading ...

Overview Company News Filings

Slammed 29% Integral Diagnostics Limited (ASX:IDX) Screens Well Here But There Might Be A Catch

Simply Wall St.

Small companies, big swings and four future leaders that stand out

Are Poor Financial Prospects Dragging Down Integral Diagnostics Limited (ASX:IDX Stock?

Simply Wall St.

Integral Diagnostics First Half 2025 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

Canaccord Genuity Upgrades Integral Diagnostics to Buy from Hold; Price Target is AU$2.90

MT Newswires Live

Integral Diagnostics Limited's (ASX:IDX) market cap dropped AU$178m last week; individual investors who hold 51% were hit as were institutions

Simply Wall St.

Integral Diagnostics Ltd (ASX:IDX) (H1 2025) Earnings Call Highlights: Strong Revenue Growth ...

BUZZ-Australia's Integral Diagnostics slumps on HY results, estimate miss

This ASX healthcare stock is crashing 30% on half year results

Integral Diagnostics Fiscal H1 Loss Narrows as Revenue Rises

MT Newswires Live

BRIEF-Integral Diagnostics H1 Net Loss AUD 0.4 Million

Corrected-Integral Diagnostics H1 Ebitda AUD 35.1 Million (Corrects Amount)

THOMSON REUTERS

Corrected-Integral Diagnostics H1 Net Income AUD -400 Thousand (Corrects Amount)

THOMSON REUTERS

Integral Diagnostics H1 EPS AUD 0.036

THOMSON REUTERS

Q Technology (Group) And 2 More Stocks That May Be Trading Below Estimated Value

Simply Wall St.

ASX Value Picks: Duratec And 2 Other Stocks That May Be Trading Below Intrinsic Estimates

Simply Wall St.

3 ASX Stocks Estimated To Be Up To 45.2% Below Intrinsic Value

Simply Wall St.

3 ASX Stocks Estimated To Be 31.3% To 41.2% Below Intrinsic Value

Simply Wall St.

3 ASX growth stocks to watch as earnings hit a turning point

Is this ASX healthcare stock ready to rocket post-merger?

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/IDX.AU/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IDX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDX.AU\",,,,,undefined,":{"symbol":"IDX.AU","market":"AU","secType":"STK","nameCN":"INTEGRAL DIAGNOSTICS LTD","latestPrice":2.27,"timestamp":1745475120000,"preClose":2.25,"halted":0,"volume":733790,"delay":0,"nameEN":"INTEGRAL DIAGNOSTICS LTD","floatShares":348359854,"shares":372215519,"eps":0.020184,"marketStatus":"Closed ANZAC Day","change":0.02,"latestTime":"04-24 16:12:00 AEST","open":2.27,"high":2.3,"low":2.26,"amount":1673984,"amplitude":0.017778,"askPrice":2.3,"askSize":44280,"bidPrice":2.25,"bidSize":5209,"shortable":3,"etf":0,"ttmEps":0.020184,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1745798400000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":2.25,"dividendRate":0.026432,"openAndCloseTimeList":[[1745452800000,1745474400000]],"volumeRatio":0.753483,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDX.AU\",,,,,undefined,":{"symbol":"IDX.AU","floatShares":348359854,"roa":"2.56%","roe":"1.14%","lyrEps":-0.259956,"volumeRatio":0.753483,"shares":372215519,"dividePrice":0.06,"high":2.3,"amplitude":0.017778,"preClose":2.25,"low":2.26,"week52Low":1.888,"pbRate":"1.22","psRate":"1.72","week52High":3.163,"institutionHeld":0,"latestPrice":2.27,"committee":-0.789489,"eps":0.020184,"divideRate":0.026432,"volume":733790,"delay":0,"ttmEps":0.020184,"open":2.27,"prevYearClose":2.876,"prevWeekClose":2.25,"prevMonthClose":2.29,"prevQuarterClose":2.29,"fiveDayClose":2.25,"twentyDayClose":2.27,"sixtyDayClose":2.886},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IDX.AU\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2516539957","title":"Slammed 29% Integral Diagnostics Limited (ASX:IDX) Screens Well Here But There Might Be A Catch","url":"https://stock-news.laohu8.com/highlight/detail?id=2516539957","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516539957?lang=en_us&edition=fundamental","pubTime":"2025-03-01 05:14","pubTimestamp":1740777266,"startTime":"0","endTime":"0","summary":"Integral Diagnostics Limited ( ASX:IDX ) shareholders that were waiting for something to happen have been dealt a blow...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-idx/integral-diagnostics-shares/news/slammed-29-integral-diagnostics-limited-asxidx-screens-well","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IDX.AU","BK7124","INTEU","IDX"],"gpt_icon":0},{"id":"2514831397","title":"Small companies, big swings and four future leaders that stand out","url":"https://stock-news.laohu8.com/highlight/detail?id=2514831397","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514831397?lang=en_us&edition=fundamental","pubTime":"2025-02-28 13:12","pubTimestamp":1740719546,"startTime":"0","endTime":"0","summary":"In our reporting season update, I talk to Jason Guthrie about another volatile reporting season in the small to mid-cap end of the ASX. As always there have been many winners and losers and I discuss the trends we are seeing, including margin pressures and a reckoning for some of the best performing companies and sectors of recent months. I also outline the performance of a some of IML’s key holdings including Mayne Pharma , oOh!Media , Integral Diagnostics  and Light & Wonder .So, it’s been very volatile, but I think if we look at the reporting season in totality, the key messages we can take away are that consumers are still fairly price-conscious and value-conscious, but it’s not diabolical in terms of how the consumer is performing. If you look at the revenue lines that many of the companies have reported this reporting season, that’s actually held up OK. Companies are growing their top line o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/small-companies-big-swings-and-four-future-leaders-that-stand-out","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/small-companies-big-swings-and-four-future-leaders-that-stand-out","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["BK7045","MYX.AU","BK7078","BK7124","SWM.AU","BK7508","BK7052","OML.AU","BK7096","LNW.AU","IDX.AU"],"gpt_icon":0},{"id":"2514359874","title":"Are Poor Financial Prospects Dragging Down Integral Diagnostics Limited (ASX:IDX Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2514359874","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514359874?lang=en_us&edition=fundamental","pubTime":"2025-02-28 06:01","pubTimestamp":1740693707,"startTime":"0","endTime":"0","summary":"With its stock down 20% over the past week, it is easy to disregard Integral Diagnostics . We decided to study the company's financials to determine if the downtrend will continue as the long-term performance of a company usually dictates market outcomes. Particularly, we will be paying attention to Integral Diagnostics'  ROE today.ROE or return on equity is a useful tool to assess how effectively a company can generate returns on the investment it received from its shareholders. In other words, it is a profitability ratio which measures the rate of return on the capital provided by the company's shareholders.Check out our latest analysis for Integral Diagnostics. Earnings growth is an important metric to consider when valuing a stock. It’s important for an investor to know whether the market has priced in the company's expected earnings growth . Doing so will help them establish if the stock's future looks promising or ominous. What is IDX worth today?The  intrinsic value infographic ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/poor-financial-prospects-dragging-down-220147228.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["INTEU","IDX","IDX.AU","BK7124"],"gpt_icon":0},{"id":"2514635334","title":"Integral Diagnostics First Half 2025 Earnings: Revenues Beat Expectations, EPS Lags","url":"https://stock-news.laohu8.com/highlight/detail?id=2514635334","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514635334?lang=en_us&edition=fundamental","pubTime":"2025-02-28 05:09","pubTimestamp":1740690551,"startTime":"0","endTime":"0","summary":"ASX:IDX Earnings and Revenue History February 27th 2025. All figures shown in the chart above are for the trailing 12 month  period. Revenue exceeded analyst estimates by 1.4%. Earnings per share  missed analyst estimates.Looking ahead, revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 6.3% growth forecast for the Healthcare industry in Australia.The company's shares are down 20% from a week ago.You should always think about risks. Case in point, we've spotted   3 warning signs for Integral Diagnostics  you should be aware of, and 2 of them are a bit concerning.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/integral-diagnostics-first-half-2025-210911625.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["INTEU","IDX.AU"],"gpt_icon":0},{"id":"2514873528","title":"Canaccord Genuity Upgrades Integral Diagnostics to Buy from Hold; Price Target is AU$2.90","url":"https://stock-news.laohu8.com/highlight/detail?id=2514873528","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514873528?lang=en_us&edition=fundamental","pubTime":"2025-02-27 17:23","pubTimestamp":1740648210,"startTime":"0","endTime":"0","summary":"Integral Diagnostics (ASX:IDX) has an average rating of outperform and price targets ranging from AU$2.50 to AU$3.87, according to analysts polled by Capital IQ.(MT Newswires covers equity, commodity ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IDX.AU","INTEU"],"gpt_icon":0},{"id":"2514406842","title":"Integral Diagnostics Limited's (ASX:IDX) market cap dropped AU$178m last week; individual investors who hold 51% were hit as were institutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2514406842","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514406842?lang=en_us&edition=fundamental","pubTime":"2025-02-27 05:53","pubTimestamp":1740606788,"startTime":"0","endTime":"0","summary":"Key Insights Integral Diagnostics' significant individual investors ownership suggests that the key decisions are...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-idx/integral-diagnostics-shares/news/integral-diagnostics-limiteds-asxidx-market-cap-dropped-au17","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IDX.AU","BK7124","INTEU","IDX"],"gpt_icon":0},{"id":"2514886770","title":"Integral Diagnostics Ltd (ASX:IDX) (H1 2025) Earnings Call Highlights: Strong Revenue Growth ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2514886770","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514886770?lang=en_us&edition=fundamental","pubTime":"2025-02-26 17:00","pubTimestamp":1740560456,"startTime":"0","endTime":"0","summary":"For the complete transcript of the earnings call, please refer to the full earnings call transcript.Integral Diagnostics Ltd  reported solid revenue growth of 7.8% and operating EBITDA growth of 8.2% for the first half of FY25.The company successfully completed its merger with Capital Health, which is expected to deliver at least $10 million in synergies, with most benefits realized in the first year.IDX has demonstrated strong patient satisfaction, with net promoter scores of 83 in Australia and 79 in New Zealand.The company is well-positioned to benefit from regulatory changes, including MRI deregulation and the national lung cancer screening program, which are expected to drive future growth.IDX has increased its free cash flow by 22.7% and improved its operating diluted earnings per share by 14.2%.IDX faced challenges with clinical staff shortages and labor cost inflation, particularly in regional areas, impacting margins.IDX's operating margin was constrained by higher clinical la","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/integral-diagnostics-ltd-asx-idx-090056598.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["IDX.AU","INTEU","IDX"],"gpt_icon":0},{"id":"2514602187","title":"BUZZ-Australia's Integral Diagnostics slumps on HY results, estimate miss","url":"https://stock-news.laohu8.com/highlight/detail?id=2514602187","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514602187?lang=en_us&edition=fundamental","pubTime":"2025-02-26 08:44","pubTimestamp":1740530685,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Integral Diagnostics slumps on HY results, estimate miss** Shares of Integral Diagnostics IDX.AX fall 29% to A$2.030, their lowest levels since February 20, 2024** Stock is currently the top loser on ASX All Ordinaries Index .AORD** The medical imaging services provider reports HY loss attributable of A$396,000 , compared with a loss of A$66.8 million last year** Co also reports HY operating NPAT of A$9.8 million, missing consensus estimate of A$11.1 million ** Expects replacement and growth capex for FY25 to be between A$60 million and A$65 million** About 4.9 million shares change hands, 5.6 times the 30-day average of 870,753** Stock down 28.9% YTD, including current session's moves      ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nL3N3PH01R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7124","IDX.AU"],"gpt_icon":0},{"id":"2514024151","title":"This ASX healthcare stock is crashing 30% on half year results","url":"https://stock-news.laohu8.com/highlight/detail?id=2514024151","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514024151?lang=en_us&edition=fundamental","pubTime":"2025-02-26 08:06","pubTimestamp":1740528377,"startTime":"0","endTime":"0","summary":"The Integral Diagnostics Ltd  share price is having a day to forget on Wednesday. In morning trade, the ASX healthcare stock is down 30% to $2.00. This follows the release of the medical imaging services provider's half year results. ASX healthcare stock crashing 30% today  Revenue of $252.9 million Operating EBITDA of $46.2 million Operating net profit after tax of $8.8 million Statutory loss after tax of $0.4 million Interim dividend of 2.5 cents per share  What happened during the half?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/02/26/this-asx-healthcare-stock-is-crashing-30-on-half-year-results/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7124","INTEU","IDX.AU"],"gpt_icon":0},{"id":"2514239540","title":"Integral Diagnostics Fiscal H1 Loss Narrows as Revenue Rises","url":"https://stock-news.laohu8.com/highlight/detail?id=2514239540","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514239540?lang=en_us&edition=fundamental","pubTime":"2025-02-26 07:22","pubTimestamp":1740525720,"startTime":"0","endTime":"0","summary":"Integral Diagnostics  reported Wednesday attributable loss per diluted share in the fiscal first half narrowed to AU$0.0016, from a loss of AU$0.2862 per diluted share a year earlier.Analysts polled by Visible Alpha were expecting earnings per share of AU$0.0006.Revenue from ordinary activities for the six months Dec. 31, 2024, was AU$252.9 million, up 9% from AU$231.3 million in the same period last year. Analysts surveyed by Visible Alpha expected AU$250.6 million.The radiologist and diagnostic imaging provider replacement and growth capital expenditure for the fiscal year to reach AU$60 million to AU$65 million.The board declared an interim dividend of AU$0.025 per share, unchanged from the previous reported period, payable on April 7 to shareholders on record as of March 7.Price : $2.86, Change: $-0.030, Percent Change: -1.04%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["INTEU","IDX.AU"],"gpt_icon":0},{"id":"2514044229","title":"BRIEF-Integral Diagnostics H1 Net Loss AUD 0.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2514044229","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514044229?lang=en_us&edition=fundamental","pubTime":"2025-02-26 05:35","pubTimestamp":1740519320,"startTime":"0","endTime":"0","summary":"BRIEF-Integral Diagnostics H1 Net Loss AUD 0.4 Million\n\n\nFeb 26 (Reuters) - Integral Diagnostics H1 net debt AUD 298.7 million.\n\nH1 free cash flow AUD 29.4 million\nH1 EPS AUD 0.036\nH1 revenue AUD 249.4 million\nH1 net income AUD -400 thousand\nH1 EBITDA AUD 35.1 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nPLX621BA8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDX.AU","BK7124"],"gpt_icon":0},{"id":"2514463044","title":"Corrected-Integral Diagnostics H1 Ebitda AUD 35.1 Million (Corrects Amount)","url":"https://stock-news.laohu8.com/highlight/detail?id=2514463044","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514463044?lang=en_us&edition=fundamental","pubTime":"2025-02-26 05:16","pubTimestamp":1740518206,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nPLX621BA8:8","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7124","IDX.AU"],"gpt_icon":0},{"id":"2514204411","title":"Corrected-Integral Diagnostics H1 Net Income AUD -400 Thousand (Corrects Amount)","url":"https://stock-news.laohu8.com/highlight/detail?id=2514204411","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514204411?lang=en_us&edition=fundamental","pubTime":"2025-02-26 05:16","pubTimestamp":1740518206,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nPLX621BA8:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IDX.AU","BK7124"],"gpt_icon":0},{"id":"2514041499","title":"Integral Diagnostics H1 EPS AUD 0.036","url":"https://stock-news.laohu8.com/highlight/detail?id=2514041499","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514041499?lang=en_us&edition=fundamental","pubTime":"2025-02-26 05:16","pubTimestamp":1740518206,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nPLX621BA8:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7124","IDX.AU"],"gpt_icon":0},{"id":"2513627297","title":"Q Technology (Group) And 2 More Stocks That May Be Trading Below Estimated Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2513627297","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513627297?lang=en_us&edition=fundamental","pubTime":"2025-02-21 20:02","pubTimestamp":1740139345,"startTime":"0","endTime":"0","summary":"As global markets continue to navigate the complexities of rising inflation and monetary policy adjustments, U.S. stock indexes are climbing towards record highs, buoyed by investor optimism and strategic economic decisions. In this environment, identifying undervalued stocks can be a prudent strategy for investors seeking potential opportunities amidst market fluctuations. Evaluating factors such as strong fundamentals and growth prospects can help in recognizing stocks that may be trading...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/4111000-choice1-main-header/1585186850435","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4111000-choice1-main-header/1585186850435"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/tech/hkg-1478/q-technology-group-shares/news/q-technology-group-and-2-more-stocks-that-may-be-trading-bel","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7021","BK7015","AX1.AU","BK7124","IDX.AU","SLC.AU"],"gpt_icon":0},{"id":"2512418121","title":"ASX Value Picks: Duratec And 2 Other Stocks That May Be Trading Below Intrinsic Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2512418121","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512418121?lang=en_us&edition=fundamental","pubTime":"2025-02-20 16:02","pubTimestamp":1740038553,"startTime":"0","endTime":"0","summary":"The Australian stock market has recently experienced a downturn, with the ASX 200 index slipping back into the 8,300s after reaching record highs, driven by risk-off sentiment in financials and underwhelming results from major banks. In such a fluctuating environment, identifying undervalued stocks can be crucial for investors seeking opportunities; companies like Duratec and others that may be trading below their intrinsic value offer potential for growth as market conditions stabilize.Top 10 Undervalued Stocks Based On Cash Flows In Australia. Duratec's current trading price of A$1.71 is significantly below its estimated fair value of A$2.18, suggesting it may be undervalued based on cash flows. Earnings are forecast to grow at 14% annually, outpacing the Australian market average of 11.4%, while revenue growth is expected at 8.4% per year. Recent guidance indicates full-year revenue between A$600 million and A$640 million, reinforcing positive cash flow prospects despite moderate gr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/asx-value-picks-duratec-2-080233915.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["RPL.AU","MAD.AU","BK7055","XAO.AU","BK7090","BK7073","SFR.AU","XKO.AU","AD8.AU","BK7124","DUR.AU","ALC.AU","ALX.AU","BK7506","BK7094","BK7104","BK7132","XJO.AU","IEL.AU","BK7110","BK7064","PNR.AU","BK7503","ADT.AU","BK7062","SYL.AU","IDX.AU","BK7507","BK7095"],"gpt_icon":0},{"id":"2512789591","title":"3 ASX Stocks Estimated To Be Up To 45.2% Below Intrinsic Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2512789591","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512789591?lang=en_us&edition=fundamental","pubTime":"2025-02-19 16:02","pubTimestamp":1739952149,"startTime":"0","endTime":"0","summary":"The Australian stock market recently experienced a downturn, with the ASX 200 closing 0.83% lower at 8,410 points, largely due to weak performances in the banking and energy sectors and external economic pressures like the administration of Whyalla steelworks. In this challenging environment, identifying undervalued stocks can be crucial for investors seeking opportunities; such stocks are often trading below their intrinsic value despite potential for future growth.Top 10 Undervalued Stocks Based On Cash Flows In Australia. Overview: Adriatic Metals PLC, with a market cap of A$1.31 billion, is involved in the exploration and development of precious and base metals through its subsidiaries.Overview: Codan Limited develops technology solutions for various sectors including United Nations organizations, security and military groups, government departments, individuals, and small-scale miners, with a market cap of A$3.13 billion.Codan is trading at A$17.14, well below its estimated fair v","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-asx-stocks-estimated-45-080229996.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7083","BK7094","IDX.AU","BK7055","BK7506","BK7090","BK7084","MAD.AU","BK7110","XAO.AU","RDY.AU","BK7124","IEL.AU","BK7159","XJO.AU","ALX.AU","WHC.AU","XKO.AU","BK7132","BK7144","BK7016","SYL.AU","ADT.AU","INA.AU","BK7095","SFR.AU","BK7507","BK7064","ALC.AU","CDA.AU"],"gpt_icon":0},{"id":"2512364851","title":"3 ASX Stocks Estimated To Be 31.3% To 41.2% Below Intrinsic Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2512364851","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512364851?lang=en_us&edition=fundamental","pubTime":"2025-02-18 16:02","pubTimestamp":1739865741,"startTime":"0","endTime":"0","summary":"The Australian market is currently navigating a complex landscape, with the Reserve Bank of Australia's recent interest rate cut and mixed sector performances highlighting the challenges and opportunities for investors. In this environment, identifying undervalued stocks can be particularly rewarding, as they may offer potential growth when their intrinsic value is recognized by the market.Top 10 Undervalued Stocks Based On Cash Flows In Australia. Audinate Group is trading at A$10.41, significantly undervalued compared to its estimated fair value of A$16.03, suggesting potential upside based on discounted cash flow analysis. Despite a challenging financial period with a net loss of A$2.21 million and reduced profit margins, earnings are forecast to grow substantially at 51% annually, outpacing the Australian market's growth rate. However, return on equity remains low at 6.8%, indicating room for improvement in profitability metrics.PolyNovo is trading at A$1.92, below its fair value e","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-asx-stocks-estimated-31-080221754.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["MAD.AU","BK7055","XAO.AU","MSB.AU","BK7067","BK7090","BK7073","SFR.AU","XKO.AU","AD8.AU","BK7124","BK7126","ALC.AU","ALX.AU","BK7506","BK7501","RDY.AU","BK7094","BK7016","BK7132","PNV.AU","XJO.AU","IEL.AU","BK7110","BK7064","BK7083","WHC.AU","MLG.AU","BK7508","BK7503","SYL.AU","IDX.AU","BK7507","BK7095"],"gpt_icon":0},{"id":"2510534586","title":"3 ASX growth stocks to watch as earnings hit a turning point","url":"https://stock-news.laohu8.com/highlight/detail?id=2510534586","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510534586?lang=en_us&edition=fundamental","pubTime":"2025-02-12 14:02","pubTimestamp":1739340159,"startTime":"0","endTime":"0","summary":"This interview was recorded on Tuesday 11 February 2025.Share markets are at near-highs. The RBA is expected to start cuts next week. There’s change in the air and something that seems like…hope. FNArena’s Rudi Filapek-Vandycknotes that all reporting seasons have their own character and this one spells a significant change compared to the more depressed mood of August 2024. The optimism is back and Filapek-Vandyck points to a few key reasons.“There is a growing confidence now that earnings in Australia have bottomed, and we will see better times ahead. That’s already being reflected in forecasts,” he says.He adds that the prospect of rate cuts supports his optimism and his view that 2025 may be the year that the “60% that haven’t performed over the past two years” finally get going.The two sectors and three stocks to watch this season. “The one telecommunication company that has been put forward as potentially shooting out the lights this year is Superloop and they have been on a tear ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/3-asx-growth-stocks-to-watch-as-earnings-hit-a-turning-point","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/3-asx-growth-stocks-to-watch-as-earnings-hit-a-turning-point","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["TLX.AU","WTC.AU","XKO.AU","BK7016","BK7503","CBA.AU","BK7046","HUB.AU","INTEU","BK7054","TPG.AU","CSL.AU","XAO.AU","BK7508","BK7042","BK7015","BK7094","RHC.AU","XJO.AU","COH.AU","BK7501","BK7509","BK7067","SHL.AU","IDX.AU","ACL.AU","SLC.AU","BK7113","TLS.AU","BK7124","RMD.AU","BK7007","BK7135","PME.AU","BK7511","HLS.AU","MQG.AU"],"gpt_icon":0},{"id":"2510397238","title":"Is this ASX healthcare stock ready to rocket post-merger?","url":"https://stock-news.laohu8.com/highlight/detail?id=2510397238","media":"LiveWire","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510397238?lang=en_us&edition=fundamental","pubTime":"2025-02-12 11:50","pubTimestamp":1739332257,"startTime":"0","endTime":"0","summary":"Integral Diagnostics  had a great year in 2024; its share price was up around 50% as its business recovered from the post-Covid doldrums. It has just completed a merger with Capitol Health to make it Australia’s second largest radiology provider and we believe this has it well set up for its next phase of growth.In this podcast, I discuss why Integral Diagnostics is one of our highest conviction holdings in IML’s small and mid cap funds.It’s always great to chat to you, Marc. I’m looking forward to today. As mentioned, we’re going to talk about Integral Diagnostics, Australia’s second largest radiology provider after the merger with Capitol Health. Can you take us through their business model and why IML thinks it’s a good investment?One of the things you want to have as a player or provider in radiology is scale. If you look at IDX over a number of years, they’ve made quite a few acquisitions to gr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/is-this-asx-healthcare-stock-ready-to-rocket-post-merger","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/is-this-asx-healthcare-stock-ready-to-rocket-post-merger","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["BK7124","IDX.AU","XAO.AU","XJO.AU","XKO.AU","INTEU"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":3,"totalSize":111,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IDX.AU\",params:#limit:5,,,undefined,":[{"date":"2025-03-06","symbol":"IDX.AU","amount":0.025,"announcedDate":"2025-02-26","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-03-07","name":"INTEGRAL DIAGNOSTICS LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-07","payableDate":"2025-03-07","currency":"AUD","dateTimestamp":1741179600000,"payDate":"2025-04-07"},{"date":"2025-02-25","symbol":"IDX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740438000000,"name":null,"time":"","dateTimestamp":1740402000000,"actualEps":null},{"date":"2024-08-30","symbol":"IDX.AU","amount":0.033,"announcedDate":"2024-08-27","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2024-09-02","defaultRemindTime":1724976000000,"name":"INTEGRAL DIAGNOSTICS LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-10-03","payableDate":"2024-09-02","currency":"AUD","dateTimestamp":1724940000000,"payDate":"2024-10-03"},{"date":"2024-08-27","symbol":"IDX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724716800000,"name":null,"time":"","dateTimestamp":1724680800000,"actualEps":null},{"date":"2024-02-29","symbol":"IDX.AU","amount":0.025,"announcedDate":"2024-02-19","type":"dividend","market":"AU","newRecordDate":"2024-03-01","defaultRemindTime":1709161200000,"name":"Integral Diagnostics Ltd","recordDate":"2024-04-02","payableDate":"2024-03-01","currency":"AUD","dateTimestamp":1709125200000,"payDate":"2024-04-02"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IDX.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-08-28","recordDate":"2020-08-31","paymentDate":"2020-10-01","value":0.04,"currency":"AUD"},{"executeDate":"2021-03-01","recordDate":"2021-03-02","paymentDate":"2021-04-06","value":0.055,"currency":"AUD"},{"executeDate":"2021-09-02","recordDate":"2021-09-03","paymentDate":"2021-10-06","value":0.07,"currency":"AUD"},{"executeDate":"2022-03-01","recordDate":"2022-03-02","paymentDate":"2022-04-04","value":0.04,"currency":"AUD"},{"executeDate":"2022-09-01","recordDate":"2022-09-02","paymentDate":"2022-10-05","value":0.03,"currency":"AUD"}]}}